Register entry
Macfarlan Smith Limited
- Registered sites
- 1
- Drug products
- 4
- Live patents
- 0
- Countries
- 1
- Base
- United Kingdom
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Active ingredient (API) manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Macfarlan Smith Limited | EdinburghUnited Kingdom | Active ingredient (API) manufacture | 3002807530 |
Catalogue
Marketed products
4Showing 4 of 4.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Apomorphine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Buprenorphine | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
| - | Buprenorphine Hydrochloride | POWDER | BULK INGREDIENT |
| - | Naloxone Hydrochloride Dihydrate | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.